Hexagon Capital Partners’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2
| Closed | -$36 | – | 1354 |
|
|
2025
Q1 | $36 | Hold |
2
| – | – | ﹤0.01% | 1816 |
|
|
2024
Q4 | $34 | Hold |
2
| – | – | ﹤0.01% | 1824 |
|
|
2024
Q3 | $32 | Hold |
2
| – | – | ﹤0.01% | 1563 |
|
|
2024
Q2 | $17 | Hold |
2
| – | – | ﹤0.01% | 1445 |
|
|
2024
Q1 | $33 | Hold |
2
| – | – | ﹤0.01% | 1454 |
|
|
2023
Q4 | $32 | Hold |
2
| – | – | ﹤0.01% | 1408 |
|
|
2023
Q3 | $24 | Hold |
2
| – | – | ﹤0.01% | 1401 |
|
|
2023
Q2 | $28 | Hold |
2
| – | – | ﹤0.01% | 1413 |
|
|
2023
Q1 | $29 | Hold |
2
| – | – | ﹤0.01% | 1434 |
|
|
2022
Q4 | $33 | Hold |
2
| – | – | ﹤0.01% | 1442 |
|
|
2022
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 1410 |
|
|
2022
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 1233 |
|
|
2022
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 972 |
|
|
2021
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 888 |
|
|
2021
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 877 |
|